We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Soleno Therapeutics Inc | NASDAQ:SLNO | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 41.15 | 36.84 | 43.97 | 0 | 13:39:10 |
From Apr 2024 to Jun 2024
| Event: | Jefferies Global Healthcare Conference |
| Day: | Wednesday, June 5, 2024 |
| Time: | 11:30 AM Eastern Time |
| Event: | Goldman Sachs 45th Annual Global Healthcare Conference |
| Day: | Tuesday, June 11, 2024 |
| Time: | 4:00 PM ET |
A live audio webcast and replay of the events will be available in the Investors section on the Company’s website at www.soleno.life.
About Soleno Therapeutics, Inc.Soleno is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. The company’s lead candidate, DCCR extended-release tablets, a once-daily oral tablet for the treatment of PWS, recently completed its Phase 3 development program to support a planned NDA submission. For more information, please visit www.soleno.life.
Corporate Contact:Brian RitchieLifeSci Advisors, LLC212-915-2578
1 Year Soleno Therapeutics Chart |
1 Month Soleno Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
